Urodynamix Commences Enrollment In Third IAP Clinical Trial
Urodynamix Commences Enrollment In Third IAP Clinical Trial
|
Urodynamix Technologies Ltd. (TSX-V:URO) announced that enrollment has commenced in a new clinical study evaluating the safety and efficacy of its NIRS IAP Monitor investigational device. [click link for full article] |
read more...
News entry number 2147 added on Sep 17, 2007 in the Health category.
Comenteaza
Other News in the Health category
Categorie:
2. FDA Clears Unilateral Stimulation For The RT300 Functional Electrical Stimulation (FES) Motorized Cy
Categorie:
Categorie:
Categorie:
Categorie:
Related Links
- New York Methodist Hospital Set To Begin A Clinical Trial That May Help Emphysema Sufferers Breathe
- Multiple flu vaccine shows promise in clinical trials, say its makers
- Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial For Psoriasis
- New Clinical Trial To Test Effectiveness Of Vorinostat (Zolinza) On Malignant Pleural Mesothelioma
- Prostate Cancer Prevention Trial Study Reanalyzed
- Tainted blood trial nearing end for former Red Cross head
- Former Teen Bride Reads From Diary in Warren Jeffs Trial
- Five on trial in Turkey for missionary murders
- Prosecution Rests in Trial of Polygamist Warren Jeffs
News Categories
745
523
480
347
1011
693
280
973
Top 10 News
- Texas Woman Claims to Have Found Mythical 'Chupacabra'
- Google Starts Hosting News on Website
- Wireless technology hits security budgets
- Google forced to push image in China
- Western School Board limits digital devices
- 'Spooky' science points to quantum internet
- Nuñez, gov. gamble on healthcare overhaul
- Ho-hum, the guest's another candidate
- Study Focuses On Cancer Risk In Biologic Treatment For Rheumatoid Arthritis
- Microsoft purchase of RIM nice to consider, but unlikely
Statistics
News:
News Categories:
News Read:
News Categories:
News Read:
5052
8
610
8
610